GLP-1 Therapies: Where We’ve Been & Where We’re Going

When we first featured a guest discussing GLP-1 therapies, the public’s understanding of these drugs to treat obesity was still developing. In 2023, our expert was Dr. Jamy Ard, the then-incoming president of The Obesity Society. Even then, Dr. Ard was stressing that more choices would lower prices for consumers. We look back on that […] The post GLP-1 Therapies: Where We’ve Been & Where We’re Going appeared first on Healthy Communities Online.

Episode metadata supplied by the publisher feed · Published Jun 18, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP-1 Therapies: Where We’ve Been & Where We’re Going

0:00 29:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Conversations on Health Care?

This episode is 29 minutes long.

When was this Conversations on Health Care episode published?

This episode was published on June 18, 2026.

Can I download this Conversations on Health Care episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!